RayBiotech (RBI) has executed a master services and supply agreement with the Proteomics and Metabolomics Core Facility of Colorado State University in Fort Collin, Colorado. Under the deal, RayBiotech will offer biomarker discovery and ...
Receptos, a biopharmaceutical company, has announced that Ono Pharmaceuticals has elected to amend and expand the existing collaboration agreement between the parties to include transfer to Ono of the Receptos G-protein-coupled receptor ...
Tags: Pharmaceuticals, Receptos
Covagen has announced that the company has secured CHF42m in a tranched Series B financing with an option to obtain an additional CHF14m that would increase the total amount of the financing round to CHF56m. This financing will mainly ...
Roche and Molecular Partners have entered into a research collaboration and licensing agreement to discover, develop and commercialize several proprietary therapeutics incorporating Molecular' DARPin biologics conjugated to toxic agents ...
Tags: Roche, Molecular Partners
OncoMed Pharmaceuticals and Celgene have entered into an agreement to jointly develop and commercialize about six anti-cancer stem cell (CSC) product candidates from OncoMed's biologics pipeline, including demcizumab (OMP-21M18, Anti-DLL4). ...
Tags: clinical studies, Medicine, OncoMed
InnaVirVax, a biopharmaceutical company, has commenced a Phase II clinical trial evaluating the therapeutic properties of the VAC-3S vaccine when combined with standard antiretroviral therapy (ART) in the course of HIV-1 infection. The ...
Taiwan-based JHL Biotech and Switzerland-based Selexis have formed a biologic drug development alliance to serve the biopharmaceutical industry. JHL Biotech and Selexis have signed a non-exclusive strategic agreement to provide seamless ...
Tags: Health, Medicine, taiwan, Biologic Drug
PharmAthene, a biodefense company, announced that it has terminated its definitive merger agreement with US-based Theraclone Sciences with consent from Theraclone. The agreement provided for the merger of a wholly-owned subsidiary of ...
Navidea Biopharmaceuticals will collaborate with the University of Alabama at Birmingham (UAB) on a clinical study that will assess the safety and activity of a radiolabeled, humanized monoclonal antibody from its RIGS (radio-immuno-guided ...
Theraclone Sciences has received notification from the Biomedical Advanced Research and Development Authority (BARDA) informing the company that their proposal, 'Broad-spectrum anti-influenza A M2e fully human monoclonal antibody TCN-032: ...
Agalimmune, a biopharmaceutical company, has been created to develop innovative immunotherapeutics for the treatment of cancer, with a focus on solid tumours. The new company has been founded by an investment group comprising Loxbridge ...
Tags: solid tumours, cancer treatment
Newly developed Toyopearl AF-r Protein A HC-650F introduced by Tokyo company. Tosoh has launched its newly developed separation media Toyopearl AF-r Protein A HC-650F. The biopharmaceutical industry is growing rapidly in many developed, ...
Tags: Separation Media, Tosoh, Toyopearl
Single Cell Technology (SCT) and AB Biosciences (ABB) have entered into a collaboration to identify new therapeutic antibodies. Under the deal, SCT will use its patented platform to screen plasma cells, measure the kinetics of secreted ...
Most people take a healthy immune response for granted, as it typically remains on guard detecting a host of known and as yet unidentified pathogens that may threaten our health. Bacteria and viruses that cause the common cold, flu, ...
Innate Pharma has started a new program named IPH43, to develop an anti-MICA therapeutic antibody in oncology. The program is the newest to emerge from the company's discovery platform. MICA, which is highly polymorphic ligand of the NK ...
Tags: Innate Pharma, Anti-Mica Antibody